Smidt Heart Institute Expert Named Deputy Editor of NEJM AI | Physician-Researcher David Ouyang, MD, to Bring Longstanding Expertise to Journal Focused on Artificial Intelligence and Machine Learning

Smidt Heart Institute

One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has been named a deputy editor of NEJM AI–a newly established, peer-reviewed journal from the publishers of the highly respected, New England Journal of Medicine.

David Ouyang, MD Notes

“While there is a tremendous amount of excitement around artificial intelligence, particularly as it pertains to healthcare, there remains a gap between research findings on limited historical datasets and bringing unproven algorithms to the clinic and patients,” said Ouyang, a faculty member in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai and in the Division of Artificial Intelligence in Medicine.

Journal to Spotlight

The recently launched journal will spotlight clinical trials and practice-changing innovations, along with reviews, policy perspectives, and educational materials designed specifically for practicing physicians and clinician leaders interested in leveraging AI.

“There’s a keen interest in understanding and showcasing the results of artificial intelligence in clinical practice and deployment, particularly with an eye on patient impact,” said Ouyang.

Journal Responsibilities

As a deputy editor, Ouyang is responsible for the curation, screening and review of many of the submitted studies and editorials about cardiology. He is the only cardiologist among the NEJM AI deputy editors.

At Cedars-Sinai, Ouyang’s research focus is on cardiac imaging as well as application of artificial intelligence and data science to healthcare. A statistician by training, Ouyang said he has always been fascinated by understanding, visualizing, and interpreting data. As a cardiologist, he is interested in the generation and assessment of clinical evidence and data.

Christine M. Albert, MD, MPH, Chair of the Department of Cardiology in the Smidt Heart Institute and the Lee and Harold Kapelovitz Distinguished Chair in Cardiology Commented..

Christine M. Albert, Md
Christine M. Albert, Md, Mph

“The Smidt Heart Institute and our broader academic enterprise have benefited greatly from David’s vast knowledge and expertise in large language models, artificial intelligence, imaging and cardiology. As an innovator in the field, we are particularly honored to have David represent Cedars-Sinai, personifying our commitment to lead in AI medical applications.”

Among his research achievements, Ouyang led the first-of-its-kind, blinded, randomized clinical trial of AI in cardiology. The study found AI was superior in assessing cardiac function in echocardiograms when compared with assessments made by sonographers. The findings were published in late 2023 in the peer-reviewed journal Nature.

Ouyang has published nearly 100 academic research studies in medical journals such as Journal of the American College of Cardiology (JACC), European Heart Journal, and Circulation.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy